We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Oncology Institute Inc | NASDAQ:TOIIW | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0996 | 0.085 | 0.135 | 18 | 21:00:00 |
The acquisition of SRON is an important milestone for TOI as they continue to expand their ability to provide complete population health for oncology care. It will enable broader coverage across the Los Angeles area, providing more access to life-saving care for those who may not be able to otherwise afford treatment or transportation.
"We are thrilled to be taking this next step in our journey as we expand our radiation oncology practice locations, and look forward to serving the community with the highest quality of care," said Dan Virnich, MD, MBA, FACHE, President of The Oncology Institute. "This acquisition aligns with our strategic vision to be the leading value-based cancer care group in the U.S., and demonstrates our commitment to delivering comprehensive oncology solutions that will benefit our patients and the broader community."
The acquisition of SRON will enable TOI to offer value-based radiation oncology care to more patients in the Greater Los Angeles area.
About TOIFounded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 100+ employed clinicians and more than 700 teammates in over 60 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Contacts
Media
The Oncology Institute, Inc.Daniel Virnich, MDdanielvirnich@theoncologyinstitute.com(562) 735-3226 x 81125
Investors
Solebury Strategic Communicationsinvestors@theoncologyinstitute.com
1 Year Oncology Institute Chart |
1 Month Oncology Institute Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions